Using Virtual Reality to Teach Mindfulness to People With Migraine
Part of paid clinical trials in Boston, Massachusetts.
- Sponsor
- Brigham and Women's Hospital
- Study ID
- NCT07599228
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Episodic Migraine
- Migraine Disorders
- Migraine With Aura
- Migraine Without Aura
Eligibility Criteria
- Sex
- ALL
- Age
- 18 Years - 80 Years
- Healthy Volunteers
- Not accepted
Interventions
- ACT therapy delivered by REACT NeuroVR headset — BEHAVIORALThis is ACT/mindfulness therapy delivered via a virtual reality headset.
Study Details
The aim of this clinical trial is to learn if people with migraine can learn a type of biobehavioral therapy called Acceptance and Commitment Therapy (ACT) by using a virtual reality headset. Researchers are studying if this type of mindfulness therapy helps to decrease migraine-related disability. Participants will be randomized to treatment as usual or active virtual reality groups for four weeks. Everyone will keep symptom diaries, complete surveys, attend two clinic visits, and have two blood draws.
Key Dates
- Start date
- Jul 31, 2026
- Status verified
- May 2026
- Primary completion
- Aug 31, 2029
- Completion
- Jan 31, 2031
Study Design
- Enrollment
- 160 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- No Intervention: Treatment as usualThis group will remain on their CGRP injectable monoclonal antibody migraine preventive medication
- Active Comparator: Active TreatmentThis group will participate in the four week active virtual reality treatment and will also remain on their CGRP mAb medication.
Primary Outcome Measure
Phase one: Qualitative Interview of User Experience [ Time Frame: 2 weeks ]
Central Contacts
- carolyn bernstein, MD6177329700
- asimina lazaridou, PhD
Locations (3)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Brigham and Womens Hospital | Boston | Massachusetts | 02155 | - |
| Brigham and Women's Health Care Center | Chestnut Hill | Massachusetts | 02467 | - |
| Brigham and Women's Hospital | Chestnut Hill | Massachusetts | 02467 | - |
Find similar trials in Boston, MA
Related Studies
- Chiropractic Care for Episodic MigraineRecruiting · Brigham and Women's Hospital · Boston, Massachusetts
- A Study to Evaluate IPN10200 Safety and Efficacy in the Prevention of Episodic or Chronic Migraine in AdultsPHASE2 · Recruiting · Ipsen · Birmingham, Alabama
- A Clinical Trial to Evaluate Efficacy and Safety of Xeomin® Injections for Preventing Episodic MigrainePHASE3 · Recruiting · Merz Therapeutics GmbH · Chandler, Arizona
- Mind Body Balance for Pediatric MigraineRecruiting · Children's Hospital Medical Center, Cincinnati · Aurora, Colorado